Similar drugsTo uncover
Dosage form: & nbsppills
Composition:

For 1 tablet:

active substance: Althea medicinal herb extract (mukultin, dry extract) 50.0 mg;

Excipients: sodium hydrogen carbonate 86.5 mg, tartaric acid 158.9 mg, povidone (low molecular weight polyvinylpyrrolidone) 1.6 mg, calcium stearate 3.0 mg.

Description:Round, flat-cylindrical tablets from light gray to brownish-gray with interspersed, with a specific smell, with a risk and chamfer.
Pharmacotherapeutic group:Expectorant of plant origin
ATX: & nbsp
  • Expectorants
  • Pharmacodynamics:

    Mukaltin is a mixture of polysaccharides from the herb althea medicinal, possesses expectorant properties. Thanks to reflex stimulation, it intensifies the activity of the ciliated epithelium and the peristalsis of respiratory bronchioles in combination with increased secretion of the bronchial glands.

    Pharmacokinetics:No data available.
    Indications:

    Acute and chronic diseases of the respiratory tract, accompanied by a cough with the formation of difficult-to-detachable sputum of increased viscosity (tracheobronchitis, obstructive bronchitis, pneumonia, bronchiectasis) - as part of complex therapy.

    Contraindications:

    - Hypersensitivity to the components of the drug;

    - peptic ulcer of the stomach and duodenum;

    - children's age (up to 12 years).

    Pregnancy and lactation:

    The use of the drug during pregnancy and during breastfeeding is possible on the advice of a doctor.

    Dosing and Administration:

    Inside before eating.

    Adults and children from the age of 12: 1-2 tablets 2-3 times a day.

    Children can dissolve the pill in 1/3 cup of warm water.

    The average course of treatment is 7-14 days.

    Side effects:

    Allergic reactions.

    From the gastrointestinal tract: rarely - dyspeptic phenomena.
    Overdose:

    Until now, no cases of overdose with the use of the drug have been reported.

    Interaction:

    Mucaltin can be prescribed concomitantly with other drugs used in the treatment of bronchopulmonary diseases.

    Mucaltin should not be used concomitantly with drugs containing codeine and other antitussive medicines, as this makes it difficult to cough up thinned phlegm.

    Effect on the ability to drive transp. cf. and fur:

    The drug does not affect the ability to drive vehicles and engage in other potentially hazardous activities that require increased concentration and speed of psychomotor reactions.

    Form release / dosage:

    Tablets, 50 mg.

    Packaging:

    10 tablets per contour cell packaging made of polyvinylchloride film and aluminum foil.

    1, 2 or 3 contour mesh packages together with the instruction for use are placed in a pack of cardboard.

    For 10 tablets in a contour non-jammed package of paper laminated or of paper with a polymer coating, or of paper with a polyethylene coating, or of a material combined on a paper basis.

    1, 2 or 3 contour non-jawed packages together with the instruction for use are placed in a pack of cardboard.

    100-500 contour non-jawed packages are placed with an equal number of instructions for use directly in a box of corrugated cardboard lined with a polyethylene bag (for hospitals).

    For 30, 50 tablets in cans of polymeric for storage of medicines and vitamins or in cans of polymeric with the control of the first opening and a shock absorber, or in cans of polymeric complete with lids and a shock absorber or without it, or in vials, polymer cans with the control of the first opening, equipped with lids with silica gel.

    For 30, 50 tablets are placed in tubes of polymeric complete with a lid or tubes of polymeric stuffed with lids with silica gel inserts, or pencil cases complete with lids.

    1 jar or 1 bottle, or 1 tube, or 1 pencil box along with the instructions for use are placed in a pack of cardboard.

    Storage conditions:

    In a dry place, at a temperature not exceeding 15 ° ะก.

    Keep out of the reach of children.

    Shelf life:

    2 years.

    Do not use after expiry date.

    Terms of leave from pharmacies:Without recipe
    Registration number:LP-003271
    Date of registration:27.10.2015
    Expiration Date:27.10.2020
    The owner of the registration certificate:NGO Farmvilar, OOO NGO Farmvilar, OOO Russia
    Manufacturer: & nbsp
    Information update date: & nbsp18.05.2018
    Illustrated instructions
      Instructions
      Up